Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The risks of long-term use of proton pump inhibitors: a critical review
Megan Jaynes, Avinash B. Kumar
Therapeutic Advances in Drug Safety (2018) Vol. 10
Open Access | Times Cited: 207

Showing 1-25 of 207 citing articles:

ESPEN micronutrient guideline
Mette M. Berger, Alan Shenkin, Anna Schweinlin, et al.
Clinical Nutrition (2022) Vol. 41, Iss. 6, pp. 1357-1424
Open Access | Times Cited: 373
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing
John J. Lima, Cameron D. Thomas, Julia M. Barbarino, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 109, Iss. 6, pp. 1417-1423
Open Access | Times Cited: 216
Umbrella review of 42 systematic reviews with meta‐analyses: the safety of proton pump inhibitors
Elizabeth M. Salvo‐Halloran, Nicole Ferko, Sarah B. Cash, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 2, pp. 129-143
Closed Access | Times Cited: 56
Cumulative Use of Proton Pump Inhibitors and Risk of Dementia
Carin Northuis, Elizabeth J. Bell, Pamela L. Lutsey, et al.
Neurology (2023) Vol. 101, Iss. 18
Open Access | Times Cited: 23
The Phylogeny and Biological Function of Gastric Juice—Microbiological Consequences of Removing Gastric Acid
Tom C. Martinsen, Reidar Fossmark, Helge L. Waldum
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6031-6031
Open Access | Times Cited: 70
Salivary microbiome with gastroesophageal reflux disease and treatment
Nadia Kawar, Seon Gyeong Park, Joel Schwartz, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 49
Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes
Stacy Weitsman, Shreya Celly, Gabriela Leite, et al.
Digestive Diseases and Sciences (2021) Vol. 67, Iss. 1, pp. 224-232
Closed Access | Times Cited: 43
SAFETY OF LONG-TERM PROTON PUMP INHIBITORS: FACTS AND MYTHS
Décio Chinzon, Gerson Domingues, Nívia Jardim Tosetto, et al.
Arquivos de Gastroenterologia (2022) Vol. 59, Iss. 2, pp. 219-225
Open Access | Times Cited: 31
Encapsulation and delivery of phage as a novel method for gut flora manipulation in situ: A review
Yufan Yang, Du Hu, Geng Zou, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 634-649
Closed Access | Times Cited: 29
Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study
Andreana Foresta, Luisa Ojeda Fernandez, G Torrigiani, et al.
Drugs & Aging (2024) Vol. 41, Iss. 3, pp. 239-249
Closed Access | Times Cited: 6
LLL 44 – Module 3: Micronutrients in Chronic disease
Hanna-Liis Lepp, Karin Amrein, Oğuzhan Sıtkı Dizdar, et al.
Clinical Nutrition ESPEN (2024) Vol. 62, pp. 285-295
Open Access | Times Cited: 5
Letter regarding “Routine Prescription of Proton Pump Inhibitors in the Perioperative Period is Associated with Decreased Rates of 2-Year Revision Surgery after Total Hip and Knee Arthroplasty”
Raju Vaishya, Sudeep Khanna, Abhishek Vaish
The Journal of Arthroplasty (2025) Vol. 40, Iss. 3, pp. e15-e16
Closed Access
Comparison of continuous versus on-demand proton pump inhibitor therapy in symptom control of patients with Barrett's esophagus
Sung-Shuo Kao, Dang Wu, Seng‐Kee Chuah, et al.
Journal of the Formosan Medical Association (2025)
Open Access
Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC
Sagar Sardesai, Alexandra Thomas, Christopher Gallagher, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 21, pp. 5810-5817
Open Access | Times Cited: 32
Reduce unnecessary use of proton pump inhibitors
Barbara Farrell, Elliot Lass, Paul Moayyedi, et al.
BMJ (2022), pp. e069211-e069211
Closed Access | Times Cited: 26
Factors associated to potentially inappropriate prescribing in older patients according to STOPP/START criteria: MoPIM multicentre cohort study
Marisa Baré, Marina Lleal, S Ortonobes Roig, et al.
BMC Geriatrics (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Recent Advances in the Treatment of Eosinophilic Esophagitis
Amiko M. Uchida, Caitlin M. Burk, Marc E. Rothenberg, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2654-2663
Open Access | Times Cited: 13
Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024
Pierfrancesco Visaggi, Luisa Bertin, Andrea Pasta, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 15, pp. 2077-2088
Closed Access | Times Cited: 4
Inappropriate prescribing of drugs for peptic ulcer and gastro-esophageal reflux disease remains a matter of concern: Results from the LAPTOP-PPI cluster randomized trial
Manuela Casula, Ilaria Ardoino, Leandro Pierini, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Medication patterns and potentially inappropriate medication in patients with metastatic breast cancer: results of the BRE-BY-MED study
Lilly Brandstetter, Anna Grau, Peter U. Heuschmann, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Lingaku Lee, Irene Ramos-Álvarez, Tetsuhide Ito, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 20, pp. 5128-5128
Open Access | Times Cited: 37
Polypharmacy and multiple sclerosis: A population-based study
Aníbal Chertcoff, Huah Shin Ng, Feng Zhu, et al.
Multiple Sclerosis Journal (2022) Vol. 29, Iss. 1, pp. 107-118
Open Access | Times Cited: 21
Co-Administration of Proton Pump Inhibitors May Negatively Affect the Outcome in Inflammatory Bowel Disease Treated with Vedolizumab
Kata Szemes, Nelli Farkas, Zoltan Sipos, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 158-158
Open Access | Times Cited: 3
Long-Term Use of Proton-Pump Inhibitors: Unravelling the Safety Puzzle
Manish S Bhatnagar, Sachin Choudhari, Dattatray Pawar, et al.
Cureus (2024)
Open Access | Times Cited: 3
Exploring Clinical Outcomes and Feasibility of Blended Tube Feeds in Children
Neha Chandrasekar, Kate Dehlsen, Steven T. Leach, et al.
Journal of Parenteral and Enteral Nutrition (2020) Vol. 45, Iss. 4, pp. 685-698
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top